The week kicked off with the Super Bowl that included some colorful ads, including from Valeant which had a colorful ad for Xifaxan. Our own Meghana Keshavan attended the BIO CEO conference in New York this week and had the opportunity to interview some of the speakers, such as the founder of life science investment firm OrbiMed Samuel Isalay. It was also a big week for health IT in the UK — the government pledged to invest billions in this area as well as for remote monitoring.
Health tech reporter Neil Versel moderated a MedHeads discussion this week about the digital health investment landscape which included startups taking part in MedCity INVEST’s Startup Showcase — Teqqa and The Medical Memory and Bessemer Venture Partners.
With the Rise of AI, What IP Disputes in Healthcare Are Likely to Emerge?
Munck Wilson Mandala Partner Greg Howison shared his perspective on some of the legal ramifications around AI, IP, connected devices and the data they generate, in response to emailed questions.
Here’s a look at five must-read stories from MedCity News reporters this week.
1. A gutsy move: Valeant runs Super Bowl commercial for Xifaxan
Many figured that the pharmaceutical industry would lay low this year and not advertise during the Super Bowl: Drug pricing remains a sensitive topic to the broader public. And yet Valeant, one of the most scrutinized of the pharmas, chose to go ahead with its costly advertising plan.
2. OrbiMed’s secret sauce: A Q&A with Founder Samuel Isaly (Part One)
A Personalized Approach to Medication Nonadherence
At the Abarca Forward conference earlier this year, George Van Antwerp, managing director at Deloitte, discussed how social determinants of health and a personalized member experience can improve medication adherence and health outcomes.
Clinicaltrials.gov is a goldmine – and you find the number of candidates in human trials growing eight percent per year. There was once a time when growth was much more modest, and maybe not at all.
3. UK spending billions on health IT, remote patient monitoring
England’s National Health Service will invest £4.2 billion ($6.1 billion) on an effort to go paperless and shift chronically ill people to remote patient monitoring, multiple British news sources reported Monday. The spending includes hiring patient safety guru Dr. Robert Wachter of the University of California, San Francisco, to review IT infrastructure across the NHS.
4. What causes medical errors in cardiology? (Infographic)
All kinds of things have been blamed for medical errors and adverse outcomes. Sometimes, they’re caused by poor communication, including the failure to deliver the right medical information to the right place at the right time.
5. Private equity firm 37celsius co-founder talks about its connected health priorities
The company expects to add strategic investors in the second quarter and do its first close for its $300 million fund this year. It will start investing while it continues to raise the rest.
